Literature DB >> 10029031

Brain tissue oxygenation during hemorrhagic shock, resuscitation, and alterations in ventilation.

G T Manley1, L H Pitts, D Morabito, C A Doyle, J Gibson, M Gimbel, H W Hopf, M M Knudson.   

Abstract

OBJECTIVES: Recently developed polarographic microelectrodes permit continuous, reliable monitoring of oxygen tension in brain tissue (PbrO2). The aim of this study was to investigate the feasibility and utility of directly monitoring PbrO2 in cerebral tissue during changes in oxygenation or ventilation and during hemorrhagic shock and resuscitation. We also sought to develop a model in which treatment protocols could be evaluated using PbrO2 as an end point.
METHODS: Licox Clark-type polarographic probes were inserted in the brain tissue of 16 swine to monitor PbrO2. In eight swine, changes in PbrO2 were observed over a range of fractional concentrations of inspired O2 (FiO2) as well as during periods of hyperventilation and hypoventilation. In eight other swine, PbrO2 was monitored during a graded hemorrhage of up to 70% estimated blood volume and during the resuscitation period.
RESULTS: When FiO2 was elevated to 100%, PbrO2 increased from a baseline of 15+/-2 mm Hg to 36+/-11 mm Hg. Hyperventilation while breathing 100% oxygen resulted in a 40% decrease in PbrO2 (p < 0.05), whereas hypoventilation increased PbrO2 to 88 mm Hg (p < 0.01). A graded hemorrhage to 50% estimated blood volume significantly reduced PbrO2, mean arterial pressure, and intracranial pressure (p < 0.01). Continued hemorrhage to 70% estimated blood volume resulted in a PbrO2 of 2.9+/-1.5 mm Hg. After resuscitation, PbrO2 was significantly elevated, reaching 65+/-13 mm Hg (p < 0.01), whereas mean arterial pressure and cerebral perfusion pressure simply returned to baseline.
CONCLUSION: Directly measured PbrO2 was highly responsive to changes in FiO2, ventilatory rate, and blood volume in this experimental model. In particular, hypoventilation significantly increased PbrO2, whereas hyperventilation had the opposite effect. The postresuscitation increase in PbrO2 may reflect changes in both O2 delivery and O2 metabolism. These experiments set the stage for future investigations of a variety of resuscitation protocols in both normal and injured brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10029031     DOI: 10.1097/00005373-199902000-00011

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  6 in total

1.  Brain tissue oxygenation and cerebral perfusion pressure thresholds of ischemia in a standardized pig brain death model.

Authors:  Karlis Purins; Per Enblad; Lars Wiklund; Anders Lewén
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

Review 2.  Neuromonitoring in neurological critical care.

Authors:  Ian F Dunn; Dilantha B Ellegala; Dong H Kim; Zachary N Litvack
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

3.  Comparison between cerebral tissue oxygen tension and energy metabolism in experimental subdural hematoma.

Authors:  Troels Halfeld Nielsen; Susanne I Engell; Rikke Aagaard Johnsen; Mette K Schulz; Oke Gerke; Jacob Hjelmborg; Palle Toft; Carl-Henrik Nordström
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

4.  A Swine Model of Severe Propranolol Toxicity Permitting Direct Measurement of Brain Tissue Oxygenation.

Authors:  Benjamin S Orozco; Kristin M Engebretsen; Joel S Holger; Samuel J Stellpflug
Journal:  J Med Toxicol       Date:  2019-03-20

5.  The life-saving properties of blood: mitigating cerebral insult after traumatic brain injury.

Authors:  Shelly D Timmons
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

6.  Association of out-of-hospital advanced airway management with outcomes after traumatic brain injury and hemorrhagic shock in the ROC hypertonic saline trial.

Authors:  Henry E Wang; Siobhan P Brown; Russell D MacDonald; Shawn K Dowling; Steve Lin; Daniel Davis; Martin A Schreiber; Judy Powell; Rardi van Heest; Mohamud Daya
Journal:  Emerg Med J       Date:  2013-01-26       Impact factor: 2.740

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.